Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02226796 · ClinicalTrials.gov registry record · NA

Transcranial Direct Stimulation (tDCS) and Behavioral Intervention in Aphasia

A NA study, sponsored by University of Minnesota.

Completed
Registry status
NA
Development phase
3
Enrollment target

NCT02226796: Completed NA study, sponsored by University of Minnesota.

NCT02226796 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 3 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02226796, a NA study, has completed, sponsored by University of Minnesota.

COMPLETED
Registry status
NA
Development phase
3 participants
Enrollment target

Study Summary

We hypothesize patients who have difficulty with word recall (naming pictures) due to a stroke will experience greater benefit in word recall after receiving a combination of transcranial direct current stimulation (tDCS) and traditional behavioral treatment. This study will investigate the effects of the timing of tDCS in relationship to the behavioral treatment to determine the most optimal protocol. Transcranial direct current stimulation involves placing two electrodes on your scalp and sending a very small electrical current to excite the brain cells of the target site.

Primary Outcome

Participants are shown one or 3 possible banks of pictures balanced for phonemic complexity which are randomly assigned to prevent learning effect. Each bank contains 15 items. Time to recall is measured using a stop watch. The mean time to recall across all items is calculated and reported in milliseconds. The smaller the number, the faster / better the reaction time is.

Interventions

  • DEVICE Transcranial direct current stimulation

Trial Details

FieldValue
Enrollment Target 3 participants
Start Date 2015-09-01
Est. Completion 2018-12-01
Phase NA
University of Minnesota

966 total trials

What the finished NCT02226796 record still lists

NCT02226796 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 1 intervention - of which Transcranial direct current stimulation is the first listed.

NCT02226796 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02226796 about?

NCT02226796 is a clinical study titled "Transcranial Direct Stimulation (tDCS) and Behavioral Intervention in Aphasia". We hypothesize patients who have difficulty with word recall (naming pictures) due to a stroke will experience greater benefit in word recall after receiving a combination of transcranial direct current stimulation (tDCS) and traditional behavioral treatment. This study will investigate the effects ...

What is the current status of trial NCT02226796?

This trial is currently completed. It is a NA study. The enrollment target is 3 participants. The study started on 2015-09-01. Estimated completion is 2018-12-01.

What interventions are being tested in trial NCT02226796?

The interventions under investigation include: Transcranial direct current stimulation (DEVICE).

Who is sponsoring clinical trial NCT02226796?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02226796's enrollment target sits among peer trials

3 1996th of 2000 higher than 4 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02226796, the US trial registry maintained by the National Library of Medicine. NCT02226796 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.